[HTML][HTML] Autophagy in Alzheimer's disease pathogenesis: Therapeutic potential and future perspectives

Z Zhang, X Yang, YQ Song, J Tu - Ageing research reviews, 2021 - Elsevier
Alzheimer's disease (AD) is a complex neurodegenerative disease in the elderly and the
most common cause of human dementia. AD is characterized by accumulation of abnormal …

[HTML][HTML] Metformin in aging and aging-related diseases: clinical applications and relevant mechanisms

S Chen, D Gan, S Lin, Y Zhong, M Chen, X Zou… - Theranostics, 2022 - ncbi.nlm.nih.gov
Aging is a natural process, which plays a critical role in the pathogenesis of a variety of
diseases, ie, aging-related diseases, such as diabetes, osteoarthritis, Alzheimer disease …

Progress and challenges in targeted protein degradation for neurodegenerative disease therapy

Y Fang, J Wang, M Zhao, Q Zheng, C Ren… - Journal of Medicinal …, 2022 - ACS Publications
Neurodegenerative diseases (NDs) are currently incurable diseases that cause progressive
degeneration of nerve cells. Many of the disease-causing proteins of NDs are “undruggable” …

[HTML][HTML] Glucose metabolism and AD: evidence for a potential diabetes type 3

A González, C Calfío, M Churruca… - Alzheimer's research & …, 2022 - Springer
Background Alzheimer's disease is the most prevalent cause of dementia in the elderly.
Neuronal death and synaptic dysfunctions are considered the main hallmarks of this …

LAMP2A, LAMP2B and LAMP2C: Similar structures, divergent roles

L Qiao, J Hu, X Qiu, C Wang, J Peng, C Zhang… - Autophagy, 2023 - Taylor & Francis
ABSTRACT LAMP2 (lysosomal associated membrane protein 2) is one of the major protein
components of the lysosomal membrane. There currently exist three LAMP2 isoforms …

Long-term use of metformin and Alzheimer's disease: beneficial or detrimental effects

HM Al-Kuraishy, AI Al-Gareeb, HM Saad… - …, 2023 - Springer
Alzheimer's disease (AD) is the most common neurodegenerative disease characterized by
extracellular deposition of amyloid beta (Aβ) leading to cognitive decline. Evidence from …

[HTML][HTML] Mechanism of metformin regulation in central nervous system: Progression and future perspectives

G Cao, T Gong, Y Du, Y Wang, T Ge, J Liu - Biomedicine & …, 2022 - Elsevier
Metformin as a first-line drug for type 2 diabetes mellitus (T2DM) treatment is widely studied.
Metformin can reduce liver glucose output and improve insulin resistance. Recent evidence …

[HTML][HTML] Chaperone-mediated autophagy in neurodegenerative diseases: molecular mechanisms and pharmacological opportunities

YT Wang, JH Lu - Cells, 2022 - mdpi.com
Chaperone-mediated autophagy (CMA) is a protein degradation mechanism through
lysosomes. By targeting the KFERQ motif of the substrate, CMA is responsible for the …

[HTML][HTML] The potential role of human islet amyloid polypeptide in type 2 diabetes mellitus and Alzheimer's diseases

M Alrouji, HM Al-Kuraishy, AI Al-Gareeb… - Diabetology & Metabolic …, 2023 - Springer
Human Islet amyloid polypeptide (hIAPP) from pancreatic β cells in the islet of Langerhans
has different physiological functions including inhibiting the release of insulin and glucagon …

[HTML][HTML] Exploring the pharmacological potential of metformin for neurodegenerative diseases

MR Du, QY Gao, CL Liu, LY Bai, T Li… - Frontiers in Aging …, 2022 - frontiersin.org
Metformin, one of the first-line of hypoglycemic drugs, has cardioprotective, anti-
inflammatory and anticancer activities, in addition to its proven hypoglycemic effects …